Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

BOBS vs EQPT: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

BOBS Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 2–1 Matrix Metrics)

BOBS Overall Winner 6-Pillar Tally: BOBS 0 – 0 EQPT (6 Tie) Matrix Metrics: BOBS 2 – 1 EQPT

As of Nov 16, 2026, BOBS (BOBS) is the stronger overall head-to-head candidate over EQPT (EQPT) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). BOBS carries a Unified Composite Score of 32.0/100 (SELL) at $20.45 (N/M Forward P/E, N/A operating margin), whereas EQPT carries 44.0/100 (HOLD) at $14.73 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While EQPT currently prints a higher short-term Unified Composite Score (44.0/100 HOLD vs. BOBS 32.0/100 SELL), BOBS captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BOBS vs EQPT
BOBS US Equity Head-to-Head Winner
BOBS
Institutional Equity
$20.45
-0.39% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.42β · 55% Vol
Unified Composite Score
32.0 / 100 SELL
Tech 50.0 Fund 28.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (0.8% over 20 days), RSI 71
RSI-14: 70.9 · SMA20: $18.03 · SMA50: $16.00
EQPT US Equity
EQPT
Institutional Equity
$14.73
-4.47% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 2.34β · 127% Vol
Unified Composite Score
44.0 / 100 HOLD
Tech 45.0 Fund 49.0 Flow 50.0 Mom 54.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 46
RSI-14: 45.6 · SMA20: $15.94 · SMA50: $16.65

6-Pillar Scorecard Institutional Category Breakdown (BOBS 0 – 0 EQPT)

Columns: Metric · BOBS · EQPT
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BOBS (2) vs EQPT (1)
Institutional Metric BOBS EQPT Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
78% ($10–$23) 10% ($12–$36) Stronger Trend BOBS
Beta / 30D Volatility
Risk Regime
1.42β · 55% Vol 2.34β · 127% Vol Lower Realized Risk BOBS
Unified Institutional Score
Composite Signal
32.0 / 100 (SELL) 44.0 / 100 (HOLD) Higher Composite EQPT
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon BOBS +29.1 pp
BOBS: +37.53% · EQPT: +8.43%
3M Horizon BOBS +35.82 pp
BOBS: +11.2% · EQPT: -24.62%
6M Horizon BOBS +110.83 pp
BOBS: +72.57% · EQPT: -38.26%
1Y Horizon BOBS +74.12 pp
BOBS: +20.15% · EQPT: -53.97%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BOBS vs EQPT. Trailing 12-month operating profitability (BOBS N/A vs EQPT N/A) and valuation multiples (BOBS N/M vs EQPT N/M Forward P/E) are benchmarked directly in Pillar 4 below.

BOBS ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
EQPT ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BOBS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BOBS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
EQPT UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact EQPT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BOBS Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
EQPT Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ BOBS vs EQPT Key Questions & Quantitative Answers

As of Nov 16, 2026, BOBS (BOBS) is the stronger overall head-to-head candidate over EQPT (EQPT) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). BOBS carries a Unified Composite Score of 32.0/100 (SELL) at $20.45 (N/M Forward P/E, N/A operating margin), whereas EQPT carries 44.0/100 (HOLD) at $14.73 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While EQPT currently prints a higher short-term Unified Composite Score (44.0/100 HOLD vs. BOBS 32.0/100 SELL), BOBS captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).

BOBS and EQPT split Growth & Scale metrics: BOBS posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with EQPT at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, BOBS generates N/A in USD-normalized revenue versus N/A for EQPT. In operating R&D and SG&A reinvestment, BOBS deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for EQPT.

BOBS and EQPT trade at balanced relative valuation multiples. BOBS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas EQPT trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BOBS (N/A ROE) versus EQPT (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, BOBS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.42β · 55% Vol realized risk). By comparison, EQPT carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.34β · 127% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.